Newmedica ophthalmologist Richard Stead provided HSOC delegates with an overview of contemporary treatment options ...

Philanthropy, advocacy and artistry were jointly honored at the Glaucoma Foundation's Annual Gala on April 16, at which 300 supporters and friends gathered to celebrate the Foundation's 42nd ...

Claims from 192,793 newly diagnosed dry eye disease patients showed prescription initiation in 12.4%, indicating substantial ...

A survey found high satisfaction rates among eye care practitioners who prescribed Vyzulta to treat open-angle glaucoma or ...

Global Glaucoma Surgery Devices Market OverviewThe global glaucoma surgery devices market is projected to expand at a steady growth rate of approximately 5% over the next five years, reflecting ...

OSRX partners with pro rodeo star Sam Petersen to expand Ride with OSRX, highlighting precision, performance, and growth in ...

On March 9, 2026, SpyGlass Pharma announced positive 12-month results from its phase 1/2 trial of the Bimatoprost Drug ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today ...

Concerns have been raised regarding the support and treatment offered to a farm worker who took his own life. Michael Cooley, 55, of Owens Close in Long Stratton, was discovered by his wife Lisa ...

Lake Worth, Fla.-based See Vision Eye Institute has opened a new surgery center, according to an April 17 report from The Town-Crier. The 15,000-square-foot facility, also located in Lake Worth, has ...

Among them, Primary Angle Closure Glaucoma (PACG) is the most common type in China. Primary Angle Closure Suspect (PACS) represents the earliest morphological stage of pupillary block, serving as an ...

Different model predictions put the maximum human lifespan in the range of 120 to 130 years. Frenchwoman Jeanne Calment is ...